ADVERTISEMENT
Natco gets USFDA's tentative nod for generic Tamiflu
18 Mar 2014, 02:50 PM IST
Natco Pharma today announced that it has received tentative approval from the US health regulator to sell generic version of Roche's Tamiflu, used to prevent and treat flu.
The tentative approval of Oseltamivir Phosphate (Tamiflu) capsules by the US Food and Drug Administration is for multiple strengths of 30mg, 45 mg and 75 mg, the company said in a filing to the BSE.
The Hyderabad-based company, citing IMS data, said Tamiflu had sales of approximately $495 million for the 12 months ending September 2013.
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT